DD209738A5 - Verfahren zur herstellung des impfstoffes gegen die marek'sche krankheit - Google Patents

Verfahren zur herstellung des impfstoffes gegen die marek'sche krankheit Download PDF

Info

Publication number: DD209738A5
Authority: DD; German Democratic Republic
Prior art keywords: vaccine; virus; spga; yield; strain
Prior art date: 1982-04-22

Application number

DD25008383A

Other languages

German (de)

English (en)

Inventor

Ionel-Victor Patrascu

Original Assignee

Centrul De Cercetari Si Biopre

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-04-22

Filing date

1983-04-21

Publication date

1984-05-23

1983-04-21 Application filed by Centrul De Cercetari Si Biopre filed Critical Centrul De Cercetari Si Biopre

1984-05-23 Publication of DD209738A5 publication Critical patent/DD209738A5/de

Links

229960005486 vaccine Drugs 0.000 title claims abstract description 32
238000000034 method Methods 0.000 title claims abstract description 13
208000006758 Marek Disease Diseases 0.000 title claims abstract description 7
241000700605 Viruses Species 0.000 claims abstract description 18
241001502481 Meleagrid alphaherpesvirus 1 Species 0.000 claims abstract description 10
238000009210 therapy by ultrasound Methods 0.000 claims abstract description 9
238000004113 cell culture Methods 0.000 claims abstract description 7
229910019142 PO4 Inorganic materials 0.000 claims abstract description 6
235000021317 phosphate Nutrition 0.000 claims abstract description 6
239000013049 sediment Substances 0.000 claims abstract description 6
241000283690 Bos taurus Species 0.000 claims abstract description 5
101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 claims abstract description 5
102400000472 Sucrase Human genes 0.000 claims abstract description 5
101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 claims abstract description 5
230000000120 cytopathologic effect Effects 0.000 claims abstract description 5
235000011073 invertase Nutrition 0.000 claims abstract description 5
150000003013 phosphoric acid derivatives Chemical class 0.000 claims abstract description 5
241001465754 Metazoa Species 0.000 claims abstract description 4
244000144977 poultry Species 0.000 claims abstract description 4
239000000969 carrier Substances 0.000 claims abstract description 3
239000004005 microsphere Substances 0.000 claims abstract description 3
239000000725 suspension Substances 0.000 claims description 4
238000005119 centrifugation Methods 0.000 claims description 3
238000010790 dilution Methods 0.000 claims description 3
239000012895 dilution Substances 0.000 claims description 3
229920002307 Dextran Polymers 0.000 claims description 2
210000003837 chick embryo Anatomy 0.000 claims description 2
244000052769 pathogen Species 0.000 claims description 2
238000002360 preparation method Methods 0.000 abstract description 5
WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 abstract description 4
235000013919 monopotassium glutamate Nutrition 0.000 abstract description 4
210000002257 embryonic structure Anatomy 0.000 abstract description 3
238000004519 manufacturing process Methods 0.000 abstract description 3
241000287828 Gallus gallus Species 0.000 abstract description 2
210000004027 cell Anatomy 0.000 description 13
239000001963 growth medium Substances 0.000 description 4
238000000527 sonication Methods 0.000 description 3
230000003068 static effect Effects 0.000 description 3
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
241000204031 Mycoplasma Species 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
239000002609 medium Substances 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000000243 solution Substances 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
208000029433 Herpesviridae infectious disease Diseases 0.000 description 1
241000286209 Phasianidae Species 0.000 description 1
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000012595 freezing medium Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
210000002064 heart cell Anatomy 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000008188 pellet Substances 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000010257 thawing Methods 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DD25008383A 1982-04-22 1983-04-21 Verfahren zur herstellung des impfstoffes gegen die marek'sche krankheit DD209738A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
RO107322A RO80570B1 (ro)	1982-04-22	1982-04-22	Procedeu de preparare a vaccinului contra bolii lui marek

Publications (1)

Publication Number	Publication Date
DD209738A5 true DD209738A5 (de)	1984-05-23

Family

ID=20111418

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD25008383A DD209738A5 (de)	1982-04-22	1983-04-21	Verfahren zur herstellung des impfstoffes gegen die marek'sche krankheit

Country Status (3)

Country	Link
CS (1)	CS244931B2 (fr)
DD (1)	DD209738A5 (fr)
RO (1)	RO80570B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RO132299A3 (ro)	2017-06-06	2018-12-28	Fântână Raul Sorin	Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

1982
- 1982-04-22 RO RO107322A patent/RO80570B1/ro unknown
1983
- 1983-04-21 DD DD25008383A patent/DD209738A5/de unknown
- 1983-04-22 CS CS288883A patent/CS244931B2/cs unknown

Also Published As

Publication number	Publication date
RO80570A3 (fr)	1984-07-17
CS244931B2 (en)	1986-08-14
RO80570B1 (ro)	1984-09-30

Similar Documents

Publication	Publication Date	Title
DE69634334T2 (de)	2006-04-13	Kultivierung von lawsonia intracellularis, impfstoffe gegen lawsonia intracellularis und diagnostische agenzien
DE69327307T2 (de)	2000-08-10	Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheit
DE2851928C2 (fr)	1987-06-04
DE1617940C2 (de)	1985-05-30	Verfahren zur Gewinnung eines für die Züchtung von Viren geeigneten Zellstammes
DE2463143C2 (de)	1985-04-11	Polyvalente Rindervirus-Lebendimpfstoffe
DE2360118C3 (de)	1980-12-18	Impfstoff gegen Ferkel-Colibacillose
DD232822A5 (de)	1986-02-12	Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit
DE2120929A1 (de)	1971-11-18	Impfstoff für Geflügel gegen die Mareksche Hühnerlähme und Verfahren zu seiner Herstellung
DE1198489B (de)	1965-08-12	Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE69103130T2 (de)	1994-12-01	Zellfreies Marekskrankheitvirus-Vakzin.
DD209738A5 (de)	1984-05-23	Verfahren zur herstellung des impfstoffes gegen die marek'sche krankheit
CH616959A5 (fr)	1980-04-30
DE1176317B (de)	1964-08-20	Verfahren zur Herstellung von fuer Impf-zwecke geeigneten waessrigen Fluessigkeiten mit Tollwut-Virus
US3098011A (en)	1963-07-16	Process of producing a vaccine against distemper
DE2057544C3 (de)	1979-02-22	Impfstoff gegen ein neonatales Kälberdiarrhoevirus, Verfahren zu seiner Herstellung und seine Verwendung
CH639420A5 (en)	1983-11-15	Process for the production of an RS virus
DE1235505B (de)	1967-03-02	Verfahren zur Herstellung einer Vaccine gegen Staupe
DE3136430C2 (fr)	1989-06-08
DE2162013C3 (de)	1981-10-15	Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
DE2158293A1 (de)	1972-06-08	Beständige Viruspräparation
CH455148A (de)	1968-04-30	Verfahren zur Vermehrung des Tollwutvirus
DE2225548A1 (de)	1973-12-06	Intravenoes vertraegliche staupe- und hepatitisvaccine
AT268518B (de)	1969-02-10	Verfahren zur Herstellung eines lebenden Mumpsvirus
AT264000B (de)	1968-08-12	Verfahren zur Herstellung eines abgeschwächten, zur Immunisierung von Menschen gegen Masern geeigneten Virus
DE2132911C2 (de)	1984-01-19	Verfahren zum Herstellen eines stark abgeschwächte Rötelviren enthaltenden Impfstoffs